Central retinal vein occlusion complicating treatment with intravenous immunoglobulin
Authors:
- K A C HarknessKHK A C Harkness
- P GouldingPGP Goulding
- 1 July 2000
- journal article
- Published by Springer Nature in Eye
- Vol. 14 (4) , 662-663
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- IVIG Adverse Reactions: Potential Role of Cytokines and Vasoactive SubstancesVox Sanguinis, 1998
- Iatrogenic Central Retinal Vein Occlusion and Hyperviscosity Associated with High-dose Intravenous Immunoglobulin AdministrationAmerican Journal of Ophthalmology, 1997
- Human Immunoglobulins Inhibit Thrombin-induced Ca2+ Movements and Nitric Oxide Production in Endothelial CellsJournal of Biological Chemistry, 1996
- Systemic Factors Contributory to Retinal Vein OcclusionArchives of internal medicine (1960), 1978
- Systemic factors contributory to retinal vein occlusionArchives of internal medicine (1960), 1978